Group 1 - The core viewpoint of the article highlights the successful IPO of Easy Health (02661), which received a subscription of HKD 620.4 billion from brokers, resulting in an oversubscription of 1029.8 times against a public offering amount of HKD 60.19 million [1] - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company is expected to be listed on December 23, with CICC and China Merchants Securities International as joint sponsors [1] Group 2 - Easy Health, established in 2014, provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - According to a report by Sullivan, Easy Health ranks 10th in China's digital integrated health services and health insurance market based on projected revenue for 2024, and 7th in the digital health services market [1] - The company, formerly known as "Qing Song Chou," transitioned from being a major online disease crowdfunding platform to a health service provider, obtaining an insurance brokerage license in 2016 and rebranding in 2019 [1] Group 3 - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing a total investment of RMB 100 million, which translates to 4.8018 million shares at the offering price of HKD 22.68 per share [2] - Financial projections indicate that Easy Health expects revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025, respectively, with corresponding profits of RMB 73.616 million, RMB 10.398 million, and RMB 86.045 million [2] - The net proceeds from the fundraising will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]
新股消息 轻松健康(02661)招股结束 孖展认购额达620.4亿港元 超购1029.8倍